The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities
Clinical & Translational Immunology · 2023-01 · 12 (6)
DOI: 10.1002/cti2.1454 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Translational Immunology, online erschienen am 17.06.2023. Verfasst von Ali Afrasiabi und 3 weiteren Autor:innen. Beteiligte Einrichtung: EBV Molecular Lab, Centre for Immunology and Allergy Research, Westmead Institute for Medical Research University of Sydney Sydney NSW Australia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Trish Multiple Sclerosis Research Foundation.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic neurodegenerative autoimmune disease, characterised by the demyelination of neurons in the central nervous system. Whilst it is unclear what precisely leads to MS, it is believed that genetic predisposition combined with environmental factors plays a pivotal role. It is estimated that close to half the disease risk is determined by genetic factors. However, the risk of developing MS cannot be attributed to genetic factors alone, and environmental factors are likely to play a significant role by themselves or in concert with host genetics. Epstein–Barr virus (EBV) infection is the strongest known environmental risk factor for MS. There has been increasing evidence that leaves little doubt that EBV is necessary, but not sufficient, for developing MS. One plausible explanation is EBV may alter the host immune response in the presence of MS risk alleles and this contributes to the pathogenesis of MS. In this review, we discuss recent findings regarding how EBV infection may contribute to MS pathogenesis via interactions with genetic risk loci and discuss possible therapeutic interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- EBV Molecular Lab, Centre for Immunology and Allergy Research, Westmead Institute for Medical Research University of Sydney Sydney NSW Australia.
- The Graduate School of Biomedical Engineering University of New South Wales Sydney NSW Australia.
- Kirby Institute University of New South Wales Sydney NSW Australia.
- RNA Institute University of New South Wales Sydney NSW Australia.
- Department of Medicine Western Sydney University Sydney NSW Australia.
- Biomedical Informatics and Digital Health, School of Medical Sciences, Faculty of Medicine and Health The University of Sydney Sydney NSW Australia.
ORCID-Profile: Grant P Parnell
Förderung
- Trish Multiple Sclerosis Research Foundation
Zitieren
APA
Afrasiabi, A., Ahlenstiel, C., Swaminathan, S., & Parnell, G. P. (2023). The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities. Clinical & Translational Immunology, 12(6). https://doi.org/10.1002/cti2.1454
Vancouver
Afrasiabi A, Ahlenstiel C, Swaminathan S, Parnell GP. The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities. Clinical & Translational Immunology. 2023;12(6). doi:10.1002/cti2.1454
BibTeX
@article{Afrasiabi2023,
author = {Afrasiabi, Ali and Ahlenstiel, Chantelle and Swaminathan, Sanjay and Parnell, Grant P},
title = {The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities},
journal = {Clinical & Translational Immunology},
year = {2023},
volume = {12},
number = {6},
doi = {10.1002/cti2.1454}
}
EUVIMED